Chargement en cours...
Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer
Endocrine therapies targeting oestrogen signalling have significantly improved breast cancer management. However, their efficacy is limited by intrinsic and acquired resistance to treatment, which remains a major challenge for oestrogen receptor α (ERα)-positive tumours. Though many studies using in...
Enregistré dans:
| Publié dans: | Int J Mol Sci |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6600329/ https://ncbi.nlm.nih.gov/pubmed/31195751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20112773 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|